CHELMSFORD, MASS.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today reported that A. Ernest Whiton, its Chief Financial Officer and Vice President of Administration, is entering into a 10b5-1 sales plan for the sale of up to 40,000 shares of ZOLL common stock over an approximate 12-month period. It is expected that approximately 10,000 shares, on average, will be sold each quarter, depending on market conditions, commencing in the first quarter of fiscal 2008, by Mr. Whiton pursuant to the plan. The shares to be sold will be acquired upon the exercise of stock options which were granted to Mr. Whiton between four and seven years ago. This new plan follows a 10b5-1 sales plan entered into by Mr. Whiton in September 2006.
